Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines

Both human and non-human simian adenoviruses (HAdVs and SAdVs, respectively) have been used as gene therapy and vaccine vectors. The high prevalence of HAdVs and the neutralizing antibodies associated with prior infection, may limit HAdV-based vector use in human subjects. To overcome this drawback,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Wendong, Quan, Lulu, Li, Yiqiang, Ou, Junxian, Duan, Biyan, Mei, Ting, Tan, Xiao, Chen, Weiwei, Feng, Liqiang, Wan, Chengsong, Zhao, Wei, Chodosh, James, Seto, Donald, Zhang, Qiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617444/
https://www.ncbi.nlm.nih.gov/pubmed/37712705
http://dx.doi.org/10.1128/jvi.01014-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617444/
https://www.ncbi.nlm.nih.gov/pubmed/37712705
http://dx.doi.org/10.1128/jvi.01014-23

Ejemplares similares